Physician
Kerman, Karen
Kerman, Karen was paid $407K by Medicaid between Mar 2018 and Oct 2022, across 9 billing codes. Its largest line is 64644, — 70% of everything it billed.
33Billing provider infoKERMAN, KAREN
FOXBORO, MA 02035
FOXBORO, MA 02035
33aNPI1518911767assigned 05/20/2006
28Total paid$407K
24GClaims1,193
24DCodes billed9
24AFirst – last monthMar 2018 – Oct 2022
Compared with peers
Next to other Neurology with Special Qualifications in Child Neurology Physician providers in Massachusetts
Rank by total paid#2 of 20
Median peer was paid$13K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 329 | $65K | |
| 2019 | 140 | $97K | |
| 2020 | 96 | $36K | |
| 2021 | 389 | $116K | |
| 2022 | 239 | $93K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 64644 | 70% | 466 | 407 | $286K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 19% | 50 | 43 | $76K |
| 64643 | 3.5% | 155 | 115 | $14K | |
| 95873 | 2.5% | 308 | 263 | $10K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 81 | 77 | $10K |
| 64645 | 1.5% | 67 | 65 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 16 | 16 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 37 | 36 | $1K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 13 | 12 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.